D-0376-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 26, 2022
- Initiation Date
- January 7, 2022
- Termination Date
- December 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18,456 bottles
Product Description
Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
Reason for Recall
Failed Stability Specifications
Distribution Pattern
Nationwide within the United States including Puerto Rico
Code Information
Lots #: 678900, 682000, 682400, Exp. 5/31/2022; 680600, 680800, 681000 Exp. 5/30/2022; 683200, 685200 Exp. 6/30/2022; 728900, 733100 Exp. Date 12/31/2022; 738600 Exp. 1/31/2023; 740600, 741600 Exp. 2/28/2023; 749800, 750900, 752400 Exp. 3/31/2023; 775700 Exp. 6/30/2023